Results of point-of-care manufacturing of bispecific chimeric antigen receptor (CAR) LV20.19 CAR-TCELLS in a phase i study for relapsed/refractory (R/R), non-hodgkin lymphoma (NHL)
Year: 2019
Type: article
Study design: Clinical Trial
Source: Cytotherapy
Authors: F. Zhu, N. Shah, D. Schneider, H. Xu, K. Chaney, L. Luib, C. Keever-Taylor, B. Dropulic, R. Orentas, P. Hari, B. Johnson
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2944888781